Quantitative Refractive Crosslinking in Presbyopia Aged Patients
ConditionPresbyopia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorTECLens, Inc.
About this trial
An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.
Eligibility criteria
Qualifiers
Adults aged 40-65 years
Healthy cornea
Refractive error between +4.0 D and -5.0 D
Phakic or monofocal pseudophakic (≥6 months post IOL placement)
Disqualifiers
Corneal dystrophy, scarring, or prior corneal crosslinking
Astigmatism >1.0 D
Active ocular infection, inflammation, or uncontrolled dry eye
Advanced glaucoma or diabetic retinopathy
Trial design
Treatments tested in this trial
- Quantitative refractive crosslinking
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
TECLens, Inc.
Lead sponsor
Renato Ambrósio, MD - Rio Vision; Tijuca Rio de Janeiro, Brazil
Collaborator
Juan Batlle, Jr. MD - Laser Center; Santo Domingo, Dominican Rep.
Collaborator
Source ClinicalTrials.gov